Collège Charles-Lemoyne de Longueuil Inc
Collège Charles-Lemoyne de Longueuil Inc is a Canadian nonprofit organization operating private educational institutions. The organization is best known for its two campuses of Collège Charles-Lemoyne, located in Longueuil and Sainte-Catherine, near Montreal, Quebec.
Overview
Collège Charles-Lemoyne operates as a private high school offering education from preschool (4 and 5 years old) to secondary school levels. It is part of the French-language educational system in Quebec and includes an international academy offering bilingual education at the primary level.
Educational Services
- Preschool and Primary Education: The school provides an international bilingual program at the primary level, fostering both linguistic and cultural diversity.
- Secondary Education: The Collège Charles-Lemoyne offers secondary education at its two campuses, providing a comprehensive curriculum designed to prepare students for post-secondary studies.
Campus Locations
- Longueuil – Saint-Lambert Campus: Provides secondary education with a focus on academic excellence and student development.
- Sainte-Catherine Campus: Another site for secondary education, offering similar programs and opportunities as the Longueuil campus.
Organization Structure
Collège Charles-Lemoyne de Longueuil Inc operates within a structured organizational framework, with leadership roles and various administrative positions dedicated to ensuring the quality of education and student success.
Registration and Legal Status
The organization is registered under the Business Registration Number 106952864RR0001, denoting its status as a recognized legal entity in Canada.
Edit WikiICO
106952864
Web
Sign in to see organisation website
Address
LONGUEUIL
From Social media
News about from their social media (Facebook and X).
Data about organisation
LONGUEUIL
Organisations from COLLEGE CHARLES-LEMOYNE DE LONGUEUIL INC
1. Conseil Monteregien de la Culture et des Communications
Fondé en 1977, Culture Montérégie regroupe et représente les artistes professionnels et les organismes culturels de la Montérégie.
2. ASSOCIATION NATIONALE D'INTERVENTION POUR LE MIEUX-ETRE DES ANIMAUX (ANIMA-QUEBEC) INC.
ANIMA-Québec est un OBNL qui a comme mission de rehausser le bien-être des chiens et des chats du Québec par des activités d’évaluation et de communication.
Organisme communautaire de la Montérégie, met en œuvre les conditions nécessaires pour que chaque jeune surmonte ses obstacles et trouve son propre sens à sa vie, en lui offrant des services éducatifs et sociaux personnalisés.
LE THÉÂTRE MOTUS Le théâtre qui bouge et qui remue.
Carrefour pour Elle est une maison d'aide et d'hébergement pour femmes victimes de violence conjugale avec ou sans enfants.
Interesting nearby
Interesting organisations close by to residence of COLLEGE CHARLES-LEMOYNE DE LONGUEUIL INC
Établi à Saint-Lambert depuis 1910.
Join us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News
Great news from Canada! 🇨🇦 The government is committed to using local talent for infrastructure and housing projects, supporting communities and boosting the economy! #BuildLocal #PositiveChange
Ottawa hopes Canadian labour will support building agenda, Hajdu says
Pulse24.com
Like CommentGreat news from Canada! 🇨🇦 The government is investing millions to help foreign-trained workers get their credentials recognized and is expanding skilled-trades training. Plus, there's a new tax credit for personal support workers! 🌟 Exciting steps towards a more inclusive job market! #GoodNews
Ottawa hopes Canadian labour will support building agenda, Hajdu says
The Star
Like Comment"Great news from Canada! 🇨🇦 Health Canada has just approved Lecanemab, a groundbreaking drug that helps slow early-stage Alzheimer's disease. Hope is on the horizon for many families affected by this condition. Let's continue to support research and innovation! 💙 #AlzheimersAwareness #Hope"
Health Canada authorizes long-awaited drug to slow early-stage Alzheimer's disease
The Star
Like Comment